news
Lancet calls to embrace neurodiversity in medicine
A new piece in The Lancet argues for a shift in how medicine views neurodiversity, specifically autism. It pushes for recognition of autism as a form of neurodivergence, not just a disability, but a difference that manifests based on external factors. This reframe challenges older, discredited theories on causation.
A new piece in The Lancet argues for a shift in how medicine views neurodiversity, specifically autism. It pushes for recognition of autism as a form of neurodivergence, not just a disability, but a difference that manifests based on external factors. This reframe challenges older, discredited theories on causation.
The architecture take
The conversation around neurodiversity has been stuck in 'deficit' mode for too long. This Lancet piece isn't just academic chatter; it's a call to re-evaluate how medical systems interact with conditions like autism. If we view neurodivergence not as a problem to be fixed, but as a different operating system, then interventions shift. Suddenly, the focus isn't just on masking 'symptoms' but on understanding sensory processing, social communication, and how environments impact a person's nervous system regulation. It means medical settings need to stop being inherently dysregulating for certain brain types. I've always thought the drive to 'normalize' was missing the point entirely. This is about adjusting the world, not just the individual. My hope is this nudges policy makers to think beyond diagnosis codes and toward actual support structures.